For example, in viral hepatitis leading to liver cancer development, LINC-PINT foremost contributes to inflammation during viral infection and then later, to the pathogenic properties of the cancer cells (Khatun et al., 2021a; Khatun et al., 2021b), but whether the underlying processes involved are the same in both disease stages is not clear. This evidence concerns the gene LINC-PINT and cancer.